SeeQ Diagnostics' technology is based on know-how developed in Professor Mads Albertsen's group at Aalborg University in Denmark during rapid viral variant tracking for SARS-CoV-2. This was converted into a concept, "SepSeeQ", generally applicable for any pathogen and applied in a prospective observational clinical study (n=40) at Aalborg University Hospital emergency ward. Here SepSeeQ had 100% sensitivity compared to gold-standard blood culture with MALDI-TOF pathogen identification (n=11), and further identified a relevant pathogen in an additional 11 patients (https://journals.asm.org/doi/10.1128/spectrum.03295-24)
| Website | https://seeqdiagnostics.com |
| Employees | 13 (7 on RocketReach) |
| Industry | Medical and Diagnostic Laboratories |
| Keywords | Healthcare Technology, Diagnostic Tools, Clinical Diagnostics, Digital Health, Real Time Data, Data Analytics, Quality Control, Advanced Analytics, Predictive Maintenance, Machine Learning, Remote Monitoring, Manufacturing Analytics, Big Data Solutions, Process Optimization, Biotechnology, Pharmaceutical Manufacturing, Process Automation, Drug Development |
Looking for a particular SeeQ diagnostics employee's phone or email?
SeeQ diagnostics Questions
Anders Sorensen is the CEO of SeeQ diagnostics.
7 people are employed at SeeQ diagnostics.
Top SeeQ diagnostics Employees
-
11
-
Jens Kringelum
Chief Product Officer at SeeQ diagnostics
Copenhagen, DK1 -
Morten Nielsen
Co-Founder at SeeQ diagnostics
North Denmark Region, Denmark -
Alexander Brems
Automatikspecialist at SeeQ diagnostics
Copenhagen, DK1
